Why The Commission Had No Choice But To Propose New Transition Periods For The EU IVDR
While it was obvious to those in the sector that the implementation of the EU IVD Regulation was heading for a disaster, this article looks at the facts and figures that helped sway the European Commission to propose new transition periods to better manage its implementation.
You may also be interested in...
The pressing circumstances created by the ongoing COVID-19 pandemic has resulted in the commission not only accepting compliance delays for some IVDs, but also longer transitional provisions than expected.
There is growing impetus at the highest EU levels towards ensuring the IVD Regulation is implemented as quickly and effectively as possible. Discussion at the Council of the EU have now added to this drive.
Seven changes have been made to the MedTech Europe board while the tenure of the current chair, a familiar face and well experienced in the role, has been extended for two years.